The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Who benefits from gilteritinib combination therapy amongst FLT3mut R/R AML? Genomic insights.
 
Akhil Rajendra
No Relationships to Disclose
 
Elliot Smith
No Relationships to Disclose
 
Maria Perusini
No Relationships to Disclose
 
Kenny Tang
No Relationships to Disclose
 
Eshetu Atenafu
No Relationships to Disclose
 
Aniket Bankar
No Relationships to Disclose
 
Steven Chan
No Relationships to Disclose
 
Marta Davidson
No Relationships to Disclose
 
Vikas Gupta
Stock and Other Ownership Interests - Syndax
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; CTI biophara; GlaxoSmithKline; Incyte; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI BioPharma Corp; GlaxoSmithKline; Incyte; Novartis
Research Funding - Abbvie (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on MPN24 a gene signature to predict outcome of Myelofibrosis (Inst)
 
Dawn Maze
No Relationships to Disclose
 
Mark Minden
No Relationships to Disclose
 
Guillaume Richard-Carpentier
No Relationships to Disclose
 
Aaron Schimmer
No Relationships to Disclose
 
Andre Schuh
No Relationships to Disclose
 
Karen Yee
No Relationships to Disclose
 
Hassan Sibai
No Relationships to Disclose